Deep Femoral Artery

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 291 Experts worldwide ranked by ideXlab platform

Ralph I Ruckert - One of the best experts on this subject based on the ideXlab platform.

  • aneurysms of the Deep Femoral Artery a systematic review of literature
    Zentralblatt Fur Chirurgie, 2012
    Co-Authors: Nikolaos Tsilimparis, E Faber, K Zindler, W Mohammad, U Hanack, Shida Yousefi, Ralph I Ruckert
    Abstract:

    INTRODUCTION: True aneurysms of the Deep Femoral Artery (APFA) are rare and are usually presented as case reports. Recommendations for diagnostics and therapy of APFAs are based on low-level evidence only. The purpose of this paper was to summarise the existing world experience with APFA. MATERIAL/METHODS: On the occasion of our own case a systematic review of the literature was performed for diagnostics and therapy for true APFA. Publications retrieved from PubMed, EMBASE, and the Cochrane Collaboration as well as by hand search from their references were reviewed. RESULTS: From 2002 onwards 25 papers on true APFAs were published in the English and German literature. Apart from two retrospective studies over a longer period of time these were exclusively case reports. A total of 55 true APFAs were reported in 47 patients with a mean age of 63 years. Therapeutic intervention was due to a rupture in 10 cases (18 %). The mean maximal diameter of APFA at presentation was 5.4 cm (2-18 cm). APFAs that were not ruptured presented frequently as a painful pulsatile mass in the groin and thigh. Therapeutic options for APFA included, apart from surgical resection with or without reconstruction of the Deep Femoral Artery, the endovascular repair. DISCUSSION: Symptoms of swelling and pain in the presence of a mass at the proximal thigh should raise the suspicion of an APFA. Surgical therapy should be performed electively in APFAs with a diameter of more than 2 cm or in cases of rapid progression as well as in all symptomatic or ruptured cases. The endovascular approach should be considered as an alternative option in all cases.

  • monstrous aneurysm of the Deep Femoral Artery
    American Journal of Surgery, 2009
    Co-Authors: Menedimos Geomelas, Sylvia Nikisch, Ralph I Ruckert
    Abstract:

    Abstract Deep Femoral Artery aneurysms are a rarity among arterial aneurysms. Based on a selected case of a patient who was treated at our clinic, clinical images are presented and treatment options are discussed.

Martin Schillinger - One of the best experts on this subject based on the ideXlab platform.

  • outcome after endovascular treatment of Deep Femoral Artery stenosis results in a consecutive patient series and systematic review of the literature
    Journal of Endovascular Therapy, 2006
    Co-Authors: Petra Dick, Wolfgang Mlekusch, Schila Sabeti, Jasmin Amighi, Oliver Schlager, Markus Haumer, Erich Minar, Martin Schillinger
    Abstract:

    PURPOSE: To evaluate immediate and midterm clinical outcomes after percutaneous transluminal angioplasty (PTA) of Deep Femoral Artery stenosis in patients with chronically occluded superficial Femoral arteries (SFA) and to report the results of a systematic review of the literature in this field. METHODS: A retrospective analysis was conducted of 55 consecutive patients (42 men; median age 72 years, interquartile range [IQR] 63-79) with severe intermittent claudication (n = 38) or critical limb ischemia (n = 17) who underwent balloon angioplasty of Deep Femoral Artery stenosis. Patients were followed with ankle-brachial index (ABI) measurement, estimation of maximum walking capacity, clinical staging of peripheral Artery disease (PAD), and duplex ultrasound imaging for restenosis. A systematic review of the literature using MEDLINE, EMBASE, and a hand search was done. RESULTS: Technical success (residual stenosis < 30%) was achieved in 85% (47/55), with 1 (2%) minor complication. The median ABI marginally increased from 0.48 at baseline to 0.53 post intervention without significant difference in the change of ABI between patients with supra- or infragenicular reconstitution of the femoropopliteal runoff. During a median 13-month (IQR 3-42) follow-up, no significant improvement in ABI or walking distance was maintained, and only 16 (29%) patients reported a sustained clinical improvement by 1 PAD stage. Cumulative patency and reintervention-free survival rates were, respectively, 71% and 61% at 1 year and 49% and 48% at 3 years. In the literature, only case series were found, but no randomized trial evaluating the efficacy of Deep Femoral Artery PTA. CONCLUSION: PTA of the Deep Femoral Artery can be performed with high technical success rates at a low interventional risk. However, in the majority of patients, this technique yields no sustained hemodynamic or clinical benefit. Due to a high rate of late failures, it should be reserved for limb salvage in patients without a surgical alternative.

Petra Dick - One of the best experts on this subject based on the ideXlab platform.

  • outcome after endovascular treatment of Deep Femoral Artery stenosis results in a consecutive patient series and systematic review of the literature
    Journal of Endovascular Therapy, 2006
    Co-Authors: Petra Dick, Wolfgang Mlekusch, Schila Sabeti, Jasmin Amighi, Oliver Schlager, Markus Haumer, Erich Minar, Martin Schillinger
    Abstract:

    PURPOSE: To evaluate immediate and midterm clinical outcomes after percutaneous transluminal angioplasty (PTA) of Deep Femoral Artery stenosis in patients with chronically occluded superficial Femoral arteries (SFA) and to report the results of a systematic review of the literature in this field. METHODS: A retrospective analysis was conducted of 55 consecutive patients (42 men; median age 72 years, interquartile range [IQR] 63-79) with severe intermittent claudication (n = 38) or critical limb ischemia (n = 17) who underwent balloon angioplasty of Deep Femoral Artery stenosis. Patients were followed with ankle-brachial index (ABI) measurement, estimation of maximum walking capacity, clinical staging of peripheral Artery disease (PAD), and duplex ultrasound imaging for restenosis. A systematic review of the literature using MEDLINE, EMBASE, and a hand search was done. RESULTS: Technical success (residual stenosis < 30%) was achieved in 85% (47/55), with 1 (2%) minor complication. The median ABI marginally increased from 0.48 at baseline to 0.53 post intervention without significant difference in the change of ABI between patients with supra- or infragenicular reconstitution of the femoropopliteal runoff. During a median 13-month (IQR 3-42) follow-up, no significant improvement in ABI or walking distance was maintained, and only 16 (29%) patients reported a sustained clinical improvement by 1 PAD stage. Cumulative patency and reintervention-free survival rates were, respectively, 71% and 61% at 1 year and 49% and 48% at 3 years. In the literature, only case series were found, but no randomized trial evaluating the efficacy of Deep Femoral Artery PTA. CONCLUSION: PTA of the Deep Femoral Artery can be performed with high technical success rates at a low interventional risk. However, in the majority of patients, this technique yields no sustained hemodynamic or clinical benefit. Due to a high rate of late failures, it should be reserved for limb salvage in patients without a surgical alternative.

Menedimos Geomelas - One of the best experts on this subject based on the ideXlab platform.

Erich Minar - One of the best experts on this subject based on the ideXlab platform.

  • outcome after endovascular treatment of Deep Femoral Artery stenosis results in a consecutive patient series and systematic review of the literature
    Journal of Endovascular Therapy, 2006
    Co-Authors: Petra Dick, Wolfgang Mlekusch, Schila Sabeti, Jasmin Amighi, Oliver Schlager, Markus Haumer, Erich Minar, Martin Schillinger
    Abstract:

    PURPOSE: To evaluate immediate and midterm clinical outcomes after percutaneous transluminal angioplasty (PTA) of Deep Femoral Artery stenosis in patients with chronically occluded superficial Femoral arteries (SFA) and to report the results of a systematic review of the literature in this field. METHODS: A retrospective analysis was conducted of 55 consecutive patients (42 men; median age 72 years, interquartile range [IQR] 63-79) with severe intermittent claudication (n = 38) or critical limb ischemia (n = 17) who underwent balloon angioplasty of Deep Femoral Artery stenosis. Patients were followed with ankle-brachial index (ABI) measurement, estimation of maximum walking capacity, clinical staging of peripheral Artery disease (PAD), and duplex ultrasound imaging for restenosis. A systematic review of the literature using MEDLINE, EMBASE, and a hand search was done. RESULTS: Technical success (residual stenosis < 30%) was achieved in 85% (47/55), with 1 (2%) minor complication. The median ABI marginally increased from 0.48 at baseline to 0.53 post intervention without significant difference in the change of ABI between patients with supra- or infragenicular reconstitution of the femoropopliteal runoff. During a median 13-month (IQR 3-42) follow-up, no significant improvement in ABI or walking distance was maintained, and only 16 (29%) patients reported a sustained clinical improvement by 1 PAD stage. Cumulative patency and reintervention-free survival rates were, respectively, 71% and 61% at 1 year and 49% and 48% at 3 years. In the literature, only case series were found, but no randomized trial evaluating the efficacy of Deep Femoral Artery PTA. CONCLUSION: PTA of the Deep Femoral Artery can be performed with high technical success rates at a low interventional risk. However, in the majority of patients, this technique yields no sustained hemodynamic or clinical benefit. Due to a high rate of late failures, it should be reserved for limb salvage in patients without a surgical alternative.